Carl Zeiss Meditec AG is one of the world’s leading medical technology companies. The company offers complete solutions to diagnose and treat ophthalmic diseases. In the field of microsurgery the company provides innovative visualization solutions.
Our portfolio is rounded off by promising future-oriented technologies such as intraoperative radiotherapy.
|Owners:||The Carl Zeiss Meditec AG is listed on the TecDAX of the German stock exchange (ISIN DE 0005313704); 65 percent of the shares are held by Carl Zeiss AG. The remaining shares are in free float.|
|Locations:||Besides its headquarters in Jena/ Germany, ZEISS has subsidiaries in the USA, Japan, Germany, Spain, France, Turkey and UK. Additional Research and Development Centers in India and China strengthen the company's presence in these rapidly developing economies. In other countries the company makes use of the vast distribution network of Carl Zeiss AG.|
|Revenue:||In fiscal year 2014/2015, €1.040,0 million*
|Board:||• Dr. Ludwin Monz (President and CEO)
• Dr. Christian Müller
|Employees:||The Carl Zeiss Meditec Group has about 2,900 employees worldwide,
including around 400 at the headquarters in Jena (as of September 30,
* Revenue and number of employees deviate from the published figures of the Medical Technology business group of Carl Zeiss AG as a result of different consolidation models.